SCHEMBL25577674

SCHEMBL25577674

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc(-c3cccc4oc5ccccc5c34)cc2)c2ccc(-c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.33
▸ CDC14B O60729 2/20 0.33
▸ CDC14A Q9UNH5 2/20 0.33
▸ ALOX5 P09917 1/20 0.32
▸ CA1 P00915 2/20 0.31
▸ CA2 P00918 2/20 0.31
▸ NTRK1 P04629 1/20 0.31
▸ PLK3 Q9H4B4 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CRHR1 P34998 1/20 0.31
▸ TNKS O95271 2/20 0.31
▸ MAOA P21397 2/20 0.31
▸ MAPT P10636 1/20 0.31
▸ PLA2G10 O15496 1/20 0.30
▸ PLA2G2A P14555 1/20 0.30
▸ PLA2G4A P47712 1/20 0.30
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CA12 O43570 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579374 0.99 BACE1 (0.33) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25579466 0.99 BACE1 (0.33) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25579392 0.99 BACE1 (0.33) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25579334 0.95 PLA2G2A (0.37) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25579269 0.95 BACE1 (0.32) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25577374 0.95 BACE1 (0.32) BACE1CDC14BCDC14AALOX5CA1
SCHEMBL25579513 0.94 ENPP1 (0.34) BACE1CA1CA2L3MBTL1MAPT
SCHEMBL25579361 0.94 BACE1 (0.32) BACE1CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL25577368 0.93 NPC1 (0.33) BACE1ALOX5CRHR1TNKSMAPT
SCHEMBL25579348 0.93 PLA2G2A (0.33) BACE1ALOX5CRHR1TNKSPLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 BACE1 1502/4885CDC14B 4631/4885CDC14A 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback